[Form 4] Primoris Services Corp Insider Trading Activity

Rhea-AI Filing Summary

Primoris Services Corp (PRIM) reported a routine insider transaction. A non-employee director received 302 shares of restricted common stock on 10/29/2025 under the board’s compensation program, reflecting a value of $37,500 based on the average closing price during September 2025. These shares cannot be sold for twelve months from the grant date.

Following the grant, beneficial ownership was 4,956 shares direct and 82,281 shares indirect via the Schauerman Family Trust.

Insights

Equity compensation analyst

Routine Form 4 grant; minor, time-locked award.

The disclosure lists a non-employee director award of $37,500 in restricted stock, calculated from the average closing price during September 2025, resulting in 302 shares granted on 10/29/2025. The filing notes a twelve-month sale restriction, typical for director equity.

Post-transaction holdings show 4,956 direct and 82,281 indirect shares via the Schauerman Family Trust. This appears to be a standard compensation event with limited market impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schauerman John P.

(Last) (First) (Middle)

C/O PRIMORIS SERVICES CORPORATION

2300 N. FIELD STREET, SUITE 1900

(Street)

DALLAS TX 75201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Primoris Services Corp [ PRIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		A		302	A	(1)	4,956	D
Common Stock								82,281	I	Schauerman Family Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during September 2025, resulting in a grant of 302 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.

2. Shares of Common Stock held by John P. Schauerman & Claudia H. Schauerman TR UA 08/12/10 Schauerman Family Trust.

	/s/ Kenneth M. Dodgen, Attorney-in-Fact	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PRIM disclose in this Form 4?

A non-employee director received 302 restricted shares on 10/29/2025 valued at $37,500 under the board’s compensation program.

How was the PRIM grant value determined?

The $37,500 value was based on the average closing price during September 2025, resulting in 302 shares.

Is there a lockup on the awarded PRIM shares?

Yes. The shares cannot be sold for twelve months from the date of grant.

What are the director’s PRIM holdings after the grant?

Beneficial ownership is 4,956 shares direct and 82,281 shares indirect via the Schauerman Family Trust.

What role does the reporting person hold at PRIM?

The reporting person is a Director.

Was this part of a structured plan like Rule 10b5-1?

The form includes a checkbox reference to Rule 10b5-1(c); the transaction is disclosed as a director compensation grant.